Neumora Therapeutics (NMRA) Shares Issued (2022 - 2026)

Neumora Therapeutics' Shares Issued history runs 5 years deep, the most recent figure standing at $32.4 million for Q1 2026.

• On a quarterly basis, Shares Issued rose 399.94% year-over-year to $32.4 million in Q1 2026; TTM through Mar 2026 was $32.4 million, a 399.94% increase from a year earlier, with the FY2025 full-year figure at $23.4 million, up 68.33% from the prior year.
• Shares Issued rose to $32.4 million in Q1 2026 per NMRA's latest filing, from $23.4 million in the prior quarter.
• Across five years, Shares Issued topped out at $32.4 million in Q1 2026 and bottomed at $3.0 million in Q3 2023.
• The 5-year median for Shares Issued is $13.9 million (2023), against an average of $13.9 million.
• Across the five-year window, Shares Issued sank 57.11% in 2025 and jumped 399.94% in 2026, its largest moves.
• Year by year, Shares Issued stood at $8.6 million in 2022, then surged by 60.83% to $13.8 million in 2023, then gained by 1.04% to $13.9 million in 2024, then soared by 68.33% to $23.4 million in 2025, then jumped by 38.4% to $32.4 million in 2026.
• Per Business Quant, the three latest NMRA Shares Issued figures stand at $32.4 million (Q1 2026), $23.4 million (Q4 2025), and $23.4 million (Q3 2025).